3806 NEW ZEALAND GAZETTE, No. 154 8 SEPTEMBER 2005

3. The medicines listed in Schedule 3 to this notice are
   classified as pharmacy-only medicines.
   Every reference to a medicine in this notice applies whether
   the medicine is synthetic in origin or is from biological or
   mineral sources.
   Unless specific reference is made otherwise, every reference
   applies also to medicines that are:
   (a) preparations and admixtures containing any
   proportion of any substance listed in the notice.
   (b) salts and esters of any substance listed in the notice.
   (c) preparations or extracts of biological materials listed
   in the notice.
   (d) salts or oxides of elements listed in the notice.
   Unless specific reference is made otherwise, every reference
   to a medicine applies:
   (i) if the medicine is in an injection or eye preparation,
   to any concentration of that medicine; and
   (ii) if the medicine is not in an injection or eye
   preparation, only if the concentration of the
   medicine is greater than 10 milligrams per litre or
   per kilogram.
   Where any reference is modified by a statement of the
   strength of the medicine, the strength is calculated using
   the free acid, base, alcohol or element unless specifically
   stated otherwise.

Schedule 1

Prescription Medicines
Acrivastine
Alclometasone; except when specified elsewhere in the
Schedule
Alemtuzumab
Anecortave
Antazoline; except for ophthalmic use
Azatadine; except for oral use
Bamipine
Bethanechol
Brompheniramine; except when specified elsewhere in the
Schedule
Buclizine; except for oral use
Butoconazole
Carbuterol
Chlorcyclizine
Chlorpheniramine; except when specified elsewhere in the
Schedule
Clemastine; except for oral use
Clemizole
Clobetasone; except when specified elsewhere in the
Schedule
Cyclizine; except for oral use
Cyproheptadine; except for oral use
Dexchlorpheniramine; when specified elsewhere in the
Schedule
Dibromopropamidine; except for ophthalmic use
Dichlorophen
Dimenhydrinate; except when specified elsewhere in the
Schedule
Dimethindene; except for oral use
Dimethothiazine
Diphenhydramine; except when specified elsewhere in the
Schedule
Diphenylpyraline; except when specified elsewhere in the
Schedule

Doxylamine; except when specified elsewhere in the
Schedule
Entecavir
Erlotinib
Ethyl chloride; for inhalation
Flunisolide
Fosamprenavir
Hexoprenaline
Hydrargaphen
Juniperus sabina; at all strengths
Mebhydrolin
Meclozine; except when specified elsewhere in the Schedule
Melia azedarach; at all strengths
Mepyramine; except for dermal use
Mequitazine
Mercury; except when specified elsewhere in the Schedule;
except in medicines containing 1 milligram or less per
litre or per kilogram
Methdilazine; except for oral use
Muraglitazar
Nesiritide
Nux vomica; except in medicines containing 1 milligram or
less per litre or per kilogram of strychnine
Orlistat; except when specified elsewhere in the Schedule
Pegaptanib
Pentaerithrityl tetranitrate
Phenazopyridine
Pheniramine; except when specified elsewhere in the
Schedule
Phenyltoloxamine; except for oral use
Posaconazole
Promethazine; except when specified elsewhere in the
Schedule
Propamidine; except for ophthalmic use
Solifenacin
Thenyldiamine; except when specified elsewhere in the
Schedule
Trimeprazine; except when specified elsewhere in the
Schedule
Triprolidine; except when specified elsewhere in the
Schedule

Schedule 2

Restricted Medicines
Alclometasone; for dermal use in medicines containing
0.05% or less and in packs containing not more than
30 grams which have received the consent of the
Minister or the Director-General to their distribution as
restricted medicines and are sold in the manufacturer’s
original pack
Azatadine; for oral use
Brompheniramine; for oral use except when specified
elsewhere in the Schedule
Buclizine; for oral use
Chlorpheniramine; for oral use except when specified
elsewhere in the Schedule
Clemastine; for oral use
Clobetasone; for dermal use in medicines containing 0.05%
or less and in packs containing not more than 30 grams
which have received the consent of the Minister or
the Director-General to their distribution as restricted
medicines and are sold in the manufacturer’s original
pack